BIOMAT Database Logo BIOMAT Database Logo

Experimental antitumor activity of Navelbine. 1989

S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Laboratoire de Pharmacologie et Toxicologie Fondamentales, CNRS, Toulouse, France.

UI MeSH Term Description Entries
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077235 Vinorelbine A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES. 5'-Nor-anhydrovinblastine,KW 2307,KW-2307,Navelbine,Vinorelbine Tartrate,5' Nor anhydrovinblastine,KW2307

Related Publications

S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.
February 1984, Cancer letters,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
[Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
January 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
[Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies].
September 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
November 1987, Cancer research,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Experimental antitumor activity of aminoanthraquinones.
March 1979, Cancer treatment reports,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
July 1989, Investigational new drugs,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Nitrosoureas: a review of experimental antitumor activity.
June 1976, Cancer treatment reports,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Experimental antitumor activity of new azathioprine analogues.
January 1989, Arzneimittel-Forschung,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
December 1994, Anti-cancer drugs,
S Cros, and M Wright, and M Morimoto, and H Lataste, and J P Couzinier, and A Krikorian
[Experimental study of antitumor activity of antibiotic tavromycetin].
May 1967, Antibiotiki,
Copied contents to your clipboard!